Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg
Clinical trial NCT02621905 · COMPLETED
Trial details
- NCT number
- NCT02621905
- Sponsor
- Mayne Pharma International Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.